Results 91 to 100 of about 12,305,089 (195)

Correction: Polymyxin B-induced gastric spasm: a case report. [PDF]

Front Pediatr
Sun C, Sun Y, Yang D, Hu T, Yuan L.
europepmc   +1 more source

Polymyxin B-induced gastric spasm:a case report. [PDF]

Front Pediatr
Sun C, Sun Y, Yang D, Hu T, Yuan L.
europepmc   +1 more source

Methodological Considerations on the Longitudinal Analysis of Polymyxin B‑Induced Kidney Injury [Letter]. [PDF]

Drug Des Devel Ther
Han C, Wang Y, Guo S.
europepmc   +1 more source

Marine Antimicrobial Peptide as a Promising Alternative to Polymyxin B. [PDF]

Mar Drugs
Safronova VN, Lushpa VA, Shipunova VO, Volovik MV, Dobrochaeva KL, Kruglikov RN, Bolosov IA, Dashevskii DE, Mishin AV, Batishchev OV, Korobova OV, Borzilov AI, Slashcheva GA, Dyachenko IA, Bocharov EV, Panteleev PV, Ovchinnikova TV.   +16 more
europepmc   +1 more source

A population pharmacokinetic model library for polymyxin B: clinical implementation of model-informed precision dosing. [PDF]

Front Pharmacol
Wang S, Cui X, Li L, Kang L, Hou G.
europepmc   +1 more source

Response to Letter to the Editor "Methodological Considerations on the Longitudinal Analysis of Polymyxin B‑Induced Kidney Injury" [Response to Letter]. [PDF]

Drug Des Devel Ther
Zhang GX, Qu Q, Qu J.
europepmc   +1 more source

Polymyxin B-associated hearing impairment in a patient with renal dysfunction- a case report. [PDF]

BMC Nephrol
Ni X, Ding T, Gong D, Liu X, Wang J, Wu H, Wang X.   +6 more
europepmc   +1 more source

Revisiting Polymyxin B: Pharmacokinetics, Biodistribution and Mechanism(s) of Intrarenal Transport

, 2016
Objectives: Despite dose-limiting nephrotoxic potentials, polymyxin B has re-emerged as the last line of therapy against multidrug-resistant Gram-negative bacterial infections.
Manchandani, Pooja
core  

Exposure prediction and dose optimization of polymyxin B based on bayesian and machine learning. [PDF]

Front Pharmacol
Xu Q, Li X, Huang S, Ding Q, Li Y, Yang N, Deng C, Tang B, Yang G, Pei Q.   +9 more
europepmc   +1 more source

Physiologically-based pharmacokinetic model to predict loading dose polymyxin B exposure in critically ill patients with sepsis. [PDF]

Front Pharmacol
Cao Y, Galvidis I, Alimov A, Standing JF, Burkin M, Surovoy Y.   +5 more
europepmc   +1 more source